J Korean Radiol Soc.  2001 Aug;45(2):195-200. 10.3348/jkrs.2001.45.2.195.

The Usefullness of the Transrectal Ultrasonography in the Diagnosis of the Prostate Cancer: Comparison with Systemic Sextant Biopsy

Affiliations
  • 1Department of Radiology, Seoul National University College of Medicine and the Institute of Radiation Medicine, SNUMRC.

Abstract

PURPOSE: To retrospectively compared the usefulness of the transrectal ultrasonography LEAVE A SPACE(TRUS) and systemic sextant biopsy in the diagnosis of prostate cancer.
MATERIALS AND METHODS
A total of 84 patients with clinical and laboratory findings suggestive of prostate cancer underwent TRUS and systemic sextant biopsy. Nine patients with diffuse prostatic lesion had been excluded from the list. Following sonographic evaluation, additional targeted biopsy for the focal lesion was performed in 14 patients. A total of 464 biopsy specimens were obtained and retrospectively compared with the sonographic findings.
RESULTS
For cancer, the sensitivity, specificity and false-positive rate of TRUS were 48%, 97% and 53%, respectively. The hypoechoic nodules seen in prostate cancer were more commonly located in the outer half of the peripheral zone of the prostate, while most BPH lesions were located in the inner half of this zone. Between prostate cancer and BPH there was a statistically significant difference in the location of hypoechoic nodules revealed by TRUS (p=0.01).
CONCLUSION
The location of the hypoechoic nodules provides useful information for differentiating between BPH nodoles and malignant prostatic nodules and may reduce the false-positive rate of TRUS in the diagnosis of prostate cancer.

Keyword

Prostate, US; Prostate, biopsy

MeSH Terms

Biopsy*
Diagnosis*
Humans
Prostate*
Prostatic Neoplasms*
Retrospective Studies
Sensitivity and Specificity
Ultrasonography*
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr